Glimrus PG 2mg/500mg/15mg Tablet SR
Marketer
Cagrus Biopharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimrus PG 2mg/500mg/15mg Tablet SR
Glimepiride, metformin, and pioglitazone (2mg/500mg/15mg sustained-release tablets) constitute a combined medication designed to manage blood glucose. This treatment, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It promotes efficient insulin use, thus reducing blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Ingestion with food is recommended to mitigate gastrointestinal discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed one and resume your usual schedule. Never double the dose. Overdosage can result in hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood sugar monitoring is essential. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencement, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician before use. Kidney function tests will be assessed before treatment initiation. Limit alcohol consumption to minimize the potential for heightened side effects.
Primary Ingredients of Glimrus PG 2mg/500mg/15mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Glimrus PG 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimrus PG 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimrus PG 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking. Consume with food.
Common Side effects of Glimrus PG 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimrus PG 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Glimrus PG 2mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
How Glimrus PG 2mg/500mg/15mg Tablet SR works:
Glimrus PG 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone to manage blood sugar levels. This triple-drug approach offers superior glycemic control when single or dual-agent therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, complements this action by further improving insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimrus PG 2mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimrus PG 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice before using this drug.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimrus PG 2mg/500mg/15mg tablet is likely not safe for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimrus PG 2mg/500mg/15mg SR tablets cautiously, potentially requiring dose modification. Medical advice is essential. Glimrus PG 2mg/500mg/15mg SR tablets are contraindicated in those with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimrus PG 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Glimrus PG 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimrus PG 2mg/500mg/15mg Tablet SR :
Should you forget to take a Glimrus PG 2mg/500mg/15mg Tablet SR, administer it immediately upon recollection. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glimrus PG 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently